Stage IV Breast Cancer: Abigail's Patient Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Biomarkers
- Strongly hormone-positive; germline ATM mutation
- Sex
- Female
- Spread to
- Bones
- Treatment
- surgery
- Outcome
- Living With Cancer
Treatment course, step by step
- Lumpectomy with oncoplastic reduction in June 2017; PET scans every 3 months during metastatic breast cancer care.
What happened, in summary
Abigail was 38, running a law firm, and parenting 2 young boys when she found a breast lump while tandem breastfeeding. She also looked back on back and leg pain that she later understood as bone metastases. Because her mother had a history of breast cancer, her doctor sent her for her first mammogram and diagnostic ultrasound, followed by a biopsy. On April 8, 2017, Abigail learned she had breast cancer. The cancer was first thought to be Stage IIA, but her diagnosis ultimately became Stage IV metastatic breast cancer with spread to her bones. Her cancer was strongly hormone-positive, and later genetic testing showed a germline ATM mutation. Abigail chose a lumpectomy with oncoplastic reduction rather than mastectomy, partly because she was still trying to get back to work, parenting, and daily life. The surgery took place in June 2017 after she had to stop producing breast milk so imaging and surgery could move forward. The operation removed a large area of cancer and included tissue from the other breast to preserve symmetry. As of June 2026, Abigail was living with metastatic breast cancer, continuing PET scans every 3 months, and using her legal and advocacy instincts to speak up for better care.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer